micro-community-banner
Profile Image
  • Add Media
  • Saved

1mo

Did you know? Experts highlight that relying solely on BMI may overlook important phenotypic differences in obesity and associated cardiometabolic risks. Recent consensus recommendations emphasize integrating anthropometric, biochemical, and emerging digital tools to better capture obesity heterogeneity and guide more personalized prevention and management strategies.

Could expanding obesity assessment beyond BMI help improve risk stratification and clinical decision-making in patients with obesity?

pharmacologic therapy

Could expanding obesity assessment beyond BMI help improve risk stratification and clinical decision-making in patients with obesity?

Profile Image
  • Saved

1mo
Obesity care in Chinese adults: from evidence to clinical practice - PubMed

Obesity care in Chinese adults: from evidence to clinical practice - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41446041/

More than 500 million Chinese adults suffered from overweight or obesity in 2023. The pandemic of obesity consumes healthcare and economic resources by imposing enormous burden from its complications such...

Obesity in Chinese adults is rising, driving health burden; policies, lifestyle interventions, digital health, and novel therapies are advancing care, but challenges include disparities, misdiagnosis, and need for multidisciplinary collaboration.

Profile Image
  • Saved

1mo
Profile Image
  • Saved

1mo
Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations - PubMed

Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41819567/

The rising global prevalence of obesity and its associated health problems necessitate effective intervention strategies. Historically, many anti-obesity medications have been developed and later withdrawn because of unfavorable adverse event...

Review evaluates safety of GLP-1 receptor agonists for obesity, highlighting significant weight-loss and cardiometabolic benefits while addressing adverse events such as retained gastric contents and aspiration, with clinical recommendations for safer use.

Profile Image
  • Saved

1mo
Background Image DesktopBackground Image Mobile

In 85 patients undergoing laparoscopic surgery for benign adnexal tumors, higher BMI was linked to increased abdominal wall thickness but did not significantly prolong primary trocar insertion using the open technique. Complication rates were comparable, highlighting the role of surgical experience.

Assess access strategies in obesity

Profile Image